Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (29 ops.)
Latest filing published 15 Sept 2026 for Neurocrine Biosciences INC.
Filing timeline
BuySaleDavid W. Boyer
Insider track record
Disclosed buys
0
Disclosed sells
29
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
David W. Boyer: trading record in brief
This profile gathers the share dealings of David W. Boyer in Neurocrine Biosciences Inc, where the filings describe the role as senior executive. The record holds 45 filings, for trades running from 7 February 2022 to 14 September 2026.
The open-market record consists of 29 sales worth €5.8M, with no purchase. The rest of the record consists of 8 share grants and 8 option exercises. Since January 2026: no purchases and 2 sales on the market.
On 15 September 2026 came the latest disclosure, a share grant in Neurocrine Biosciences Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to David W. Boyer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations22 total
3,587 shares0Common StockSEC:0001909817-26-000010:0
1,936 shares@ US$156.22Common StockSEC:0001909817-26-000010:1
826 shares@ US$157.4462Common StockSEC:0001909817-26-000010:2
3,888 shares@ US$156.64180.0033% mcap23.3% of flowCommon StockSEC:0001909817-26-000007:0
1,600 shares0Common StockSEC:0001909817-26-000005:0
2,096 shares0Common StockSEC:0001909817-26-000003:0
1,811 shares0Common StockSEC:0000914475-25-000059:0
1,329 shares0Common StockSEC:0000914475-25-000048:0
2,096 shares0Common StockSEC:0000914475-25-000023:0
1,295 shares@ US$113.665.9% of flowCommon StockSEC:0000914475-24-000203:0
3,461 shares@ US$121.880417.0% of flowCommon StockSEC:0000914475-24-000201:0
955 shares@ US$133.09565.3% of flowCommon StockSEC:0000914475-24-000069:0
240 shares@ US$141.961.4% of flowCommon StockSEC:0000914475-24-000051:0
1,104 shares@ US$140.87296.4% of flowCommon StockSEC:0000914475-24-000024:0
1,437 shares@ US$112.686.9% of flowCommon StockSEC:0001209191-23-052028:0
1,295 shares@ US$106.905.6% of flowCommon StockSEC:0001209191-23-047968:0
1,600 shares@ US$107.41387.0% of flowCommon StockSEC:0001209191-23-047132:0
240 shares@ US$105.6091.0% of flowCommon StockSEC:0001209191-23-007909:0
1,104 shares@ US$109.91725.0% of flowCommon StockSEC:0001209191-23-006263:0
1,295 shares@ US$114.126.6% of flowCommon StockSEC:0001209191-22-055389:0
1,437 shares@ US$106.596.9% of flowCommon StockSEC:0001209191-22-052896:0
240 shares@ US$81.070.8% of flowCommon StockSEC:0001209191-22-008250:0
22 of 22 declarations
